{"id":"W3111050887","doi":"10.1016/s0140-6736(20)32666-0","title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":364,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Saskatchewan","funders":"ViiV Healthcare","keywords":"Rilpivirine; Medicine; Human immunodeficiency virus (HIV); Internal medicine; Emtricitabine; Tenofovir; Open label; Clinical trial; Virology; Antiretroviral therapy; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005908858,0.0002567105,0.000666263,0.00005571626,0.0002701164,0.00008786194,0.0003102923,0.00009186266,0.00005386211],"category_scores_gemma":[0.0003413417,0.0001579048,0.00002712384,0.0002698445,0.0001440224,0.0002212715,0.0002336374,0.0005641143,0.0002570325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006154065,"about_ca_system_score_gemma":0.00008429524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004216734,"about_ca_topic_score_gemma":0.005996606,"domain_scores_codex":[0.9979977,0.0005906069,0.0003509928,0.0004703723,0.00007514446,0.0005151688],"domain_scores_gemma":[0.9989594,0.0003496967,0.0001507542,0.0004049744,0.00005963133,0.00007557897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.556187,0.00920676,0.3627904,0.0001895469,0.001303739,0.0007210738,0.02214112,0.00005240025,0.008339148,0.000006254533,0.006222984,0.03283964],"study_design_scores_gemma":[0.7553708,0.005165209,0.2305576,0.0002376941,0.000157531,0.00003528397,0.002403578,0.0003510908,0.001936703,0.000005972871,0.003388946,0.0003896593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938983,0.0004851398,0.00004931793,0.001366792,0.00008301027,0.003032129,0.0003045427,0.00005795568,0.0007228094],"genre_scores_gemma":[0.9985638,0.0003485724,0.00006869128,0.0001463686,0.00009969481,0.0002240365,0.0002805111,0.0000188613,0.0002494979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1991838,"threshold_uncertainty_score":0.6439171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03775309755968166,"score_gpt":0.3165012276065506,"score_spread":0.278748130046869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}